Warby Parker Inc. (NYSE: WRBY) (“Warby Parker” or the “Company”) announced the appointment of Ron Williams as Lead Director.
“Ron’s deep expertise in transformational leadership is helping Warby Parker lead the way in making the optical industry more customer and patient friendly. Our shareholders and our team are lucky to have such an exceptional and experienced leader as our first Lead Director,” said Neil Blumenthal, co-Founder and co-CEO.
ABOUT RONALD WILLIAMS
Ron Williams has served as a member of our board of directors since August 2021. Before joining Warby Parker, Mr. Williams served as the chairman and CEO of Aetna Inc. from 2006 to 2010. He joined Aetna in 2001 and was named president and joined the board in 2002. Mr. Williams is the chairman and CEO of RW2 Enterprises, through which he counsels C-Suite corporate executives. Mr. Williams also currently serves on the board of directors of agilon health, is an operating advisory to Clayton, Dubilier & Rice, and is a member of the McKinsey External Advisory Group. He has previously served on the boards of The Boeing Company, American Express, Johnson & Johnson, Envision Healthcare and naviHealth. He serves on the boards of private companies apree health (previously Castlight/Vera Whole Health Inc.) and Millennium Physician Group. Mr. Williams is chairman of The Conference Board, a member of the President’s Circle of the National Academies and was elected to the American Academy of Arts and Sciences. Mr. Williams served on President Obama’s Management Advisory Board from 2011 to 2017.
Mr. Williams holds a Bachelor of Arts from Roosevelt University and a Master of Business Administration from the Sloan School of Business at the Massachusetts Institute of Technology.
